MedTrace Logo

Safety and Effectiveness of JUVÉDERM™ Injectable Gel With Lidocaine

NCT00653861 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2014-10-13

Study results available
· View outcomes & findings →

Summary

Safety and effectiveness of JUVÉDERM™ Injectable Gel with Lidocaine compared to JUVÉDERM™ without Lidocaine for procedural pain in the treatment of nasolabial folds.

Conditions

  • Nasolabial Folds

Interventions

DEVICE

JUVÉDERM™ Injectable Gel with Lidocaine

Single treatment, volume determined by investigator

DEVICE

JUVÉDERM™ Injectable Gel

Single treatment, volume determined by investigator

Sponsors & Collaborators

  • Allergan Medical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-06-30
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00653861 on ClinicalTrials.gov